Osimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC
Osimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Osimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC have?
Osimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC has 690 citations in the OpenAlex counts ScholarIQ stores.
When was Osimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC published?
Osimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC has 2023 year in the ScholarIQ index.
What is the open-access status of Osimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC?
Osimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC has green oa status in the ScholarIQ index.
What is the DOI of Osimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC?
The DOI for Osimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC is on the source record.
What is the PMID of Osimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC?
The PMID for Osimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC is on the source record.
What is the OpenAlex record for Osimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC?
The OpenAlex for Osimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC is on the source record.